Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ EHMT1 Monoclonal Antibody (1B7B4)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA515277
Description
MA5-15277 targets GLP in indirect ELISA, WB applications and shows reactivity with Human samples. The MA5-15277 immunogen is purified recombinant fragment of GLP expressed in E. Coli.
EHMT1, also known as EUHMTASE1, is a histone methyltransferase. This protein methylates 'Lys-9' of histone H3 in vitro. H3 'Lys-9' methylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. EHMT1 is Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in the G0/G1 transition of the cell cycle.
Specifications
EHMT1 | |
Monoclonal | |
Conc. Not Determined | |
Ascites with 0.03% sodium azide | |
Q9H9B1 | |
EHMT1 | |
Purified recombinant fragment of GLP expressed in E. Coli. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA, Western Blot | |
1B7B4 | |
Unconjugated | |
EHMT1 | |
9230102N17Rik; bA188C12.1; D330003E03; EHMT1; euchromatic histone lysine methyltransferase 1; euchromatic histone methyltransferase 1; euchromatic histone-lysine N-methyltransferase 1; Euhmtase1; Eu-HMTase1; FP13812; G9a-like protein 1; GLP; GLP1; H3-K9-HMTase 5; histone H3-K9 methyltransferase 5; Histone-lysine N-methyltransferase EHMT1; histone-lysine N-methyltransferase, H3 lysine-9 specific 5; KIAA1876; KMT1D; lysine N-methyltransferase 1D; mKIAA1876 | |
Mouse | |
Protein G | |
RUO | |
79813 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction